Axogen, Inc. Common Stock (AXGN) is a publicly traded Healthcare sector company. As of May 21, 2026, AXGN trades at $42.94 with a market cap of $2.23B and a P/E ratio of -67.85. AXGN moved -0.07% today. Year to date, AXGN is +34.41%; over the trailing twelve months it is +268.97%. Its 52-week range spans $9.22 to $45.83. Analyst consensus is strong buy with an average price target of $50.14. Rallies surfaces AXGN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
AXGN financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. AXGN recently traded at $42.94. Market cap is $2.23B. P/E ratio is -67.85. Revenue is $238.10M.
| Metric | Value |
|---|---|
| Price | $42.94 |
| Market Cap | $2.23B |
| P/E Ratio | -67.85 |
| EPS | $-0.63 |
| Dividend Yield | 1.00% |
| 52-Week High | $45.83 |
| 52-Week Low | $9.22 |
| Volume | 32 |
| Avg Volume | 0 |
| Revenue (TTM) | $238.10M |
| Net Income | $-31.45M |
| Gross Margin | 75.01% |
| Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $225.21M | $-15.70M | $-0.34 |
| 2024 | $187.34M | $-9.96M | $-0.23 |
| 2023 | $159.01M | $-21.72M | $-0.51 |
| 2022 | $138.58M | $-28.95M | $-0.69 |
7 analysts cover AXGN: 0 strong buy, 7 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $50.14.